Abstract: Background: Duloxetine, which is used to treat major depressive disorder and diabetic peripheral neuropathic pain, can be analyzed with different analytical methods, including high performance liquid chromatography-tandem mass spectrometry, electrophoresis with fluorescence detection, HPLC with fluorescence detection and so on. However, these methods need time consuming sample preparations or special and expensive instruments. It is nessecary to develop a simple, rapid, sensitive and cost effective method for the determination of duloxetine in biological fluids.
INTRODUCTION
Duloxetine is a selective serotonin and norepinephrine reuptake inhibitor (SNRI) approved to treat major depressive disorder and diabetic peripheral neuropathic pain in the US and Europe [1, 2] . Its solid oral dosage form is usually available as capsules which contain 20, 30 or 60 mg of active constituent in enteric-coated pellets [3] . In the past decades, solid-phase extraction (SPE) has considerable attention as a sample preparation technique for the analysis of environmental, food and biomedical analytes [9] . However, traditional SPE is laborious and timeconsuming due to the limited rate of diffusion and mass transfer of analytes in the bulk sorbent phases packed in a cartridge [10] . Furthermore, solid particles which may exist in real samples can cause a blockage of cartridges leading to extraction failure. Magnetic dispersive solid-phase extraction (MDSPE) is a new type of SPE, which is based on the adsorption of analytes on micro-or nano-scale magnetic particles [11] . There is no need to be packed the adsorbent into the cartridges in this technique because the particles are homogenously dispersed in the sample solution during the extraction procedure. In such a dispersive mode, MDSPE not only enhances the extraction efficiency by increasing interfacial area between the solid adsorbent and sample solution, but also overcomes the problems accompany with traditional SPE which mentioned above. Another interesting property of
